Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ZANUBRUTINIB vs ZAVEGEPANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ZANUBRUTINIB vs ZAVEGEPANT: Safety Overview

Metric ZANUBRUTINIB ZAVEGEPANT
Total FAERS Reports 2,797 645
Deaths Reported 320 0
Death Rate 11.4% N/A
Hospitalizations 806 6
Average Patient Age 71.5 yrs 46.1 yrs
% Female Patients 43.0% 89.8%
FDA Approval Date Jun 10, 2025 Mar 9, 2023
Manufacturer BeOne Medicines USA, Inc. Pfizer Laboratories Div Pfizer Inc
Route ORAL NASAL
Marketing Status Discontinued Prescription